Takeda Pharmaceutical
296 hedge funds and large institutions have $1.04B invested in Takeda Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 64 increasing their positions, 105 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
296
Holders Change
+6
Holders Change %
+2.07%
% of All Funds
4.57%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
61
Increased
64
Reduced
105
Closed
52
Calls
$60.1M
Puts
$11.9M
Net Calls
+$48.3M
Net Calls Change
+$4.68M
Top Buyers
| 1 |
Citigroup
New York
|
$106M |
| 2 |
BCP
BSN Capital Partners
London,
United Kingdom
|
$63.8M |
| 3 |
Goldman Sachs
New York
|
$50.9M |
| 4 |
HT
HAP Trading
New York
|
$10.8M |
| 5 |
BlackRock
New York
|
$29.7M |
